These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23037727)

  • 21. Acute myeloid leukemia initially presenting as hemophagocytic lymphohistiocytosis--a case report and review of the literature.
    Wang LX; Fei XM; Lu YL; Shi XF; Jiang Q; You HY; Ba R; Zhu Y
    Leuk Res; 2010 Jan; 34(1):e46-9. PubMed ID: 19773082
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinically useful prognostic factors in acute myeloid leukemia.
    Ferrara F; Palmieri S; Leoni F
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):181-93. PubMed ID: 17996460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetics in AML.
    Melnick AM
    Best Pract Res Clin Haematol; 2010 Dec; 23(4):463-8. PubMed ID: 21130408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical and cytogenetics studies on acute myeloid leukemia with abnormality of chromosome 11].
    Lu Y; Xu W; Chen Z; Lou J; Jin J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):583-5. PubMed ID: 18841578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pathobiology of acute myeloid leukemia].
    Christ O; Feuring-Buske M; Hiddemann W; Buske C
    Med Klin (Munich); 2007 Apr; 102(4):290-5. PubMed ID: 17426932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of Turner syndrome associated with acute myeloid leukemia (M2).
    Patroglu T; Torun YA; Karakukcu M; Gorozen F
    J Pediatr Hematol Oncol; 2006 Oct; 28(10):682-3. PubMed ID: 17023830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological and clinical significance of cytogenetic study on 100 acute lymphoblastic leukemia and 219 acute non-lymphoblastic leukemia.
    Ye J; Cao Q; Su X; Huang Q; Ma Z; Wang Z; Huang W; Chen Z; Chen S
    Chin Med J (Engl); 1997 Feb; 110(2):90-5. PubMed ID: 9594276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular markers in acute myeloid leukemia.
    Marcucci G
    Clin Adv Hematol Oncol; 2009 Jul; 7(7):448-51. PubMed ID: 19701151
    [No Abstract]   [Full Text] [Related]  

  • 29. Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML.
    Hasle H; Abrahamsson J; Arola M; Karow A; O'Marcaigh A; Reinhardt D; Webb DK; van Wering E; Zeller B; Zwaan CM; Vyas P
    Leukemia; 2008 Jul; 22(7):1428-30. PubMed ID: 18059480
    [No Abstract]   [Full Text] [Related]  

  • 30. Loss of the Y chromosome in smoldering acute leukemia.
    Majolino I; Pasquali F; Francesconi D; Invernizzi R; Nalli G; Ascari E
    Haematologica; 1977 Apr; 62(2):144-55. PubMed ID: 406172
    [No Abstract]   [Full Text] [Related]  

  • 31. TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis.
    Bowen D; Groves MJ; Burnett AK; Patel Y; Allen C; Green C; Gale RE; Hills R; Linch DC
    Leukemia; 2009 Jan; 23(1):203-6. PubMed ID: 18596741
    [No Abstract]   [Full Text] [Related]  

  • 32. Der(1;16)(q10;p10) in acute myeloid leukemia: the first female case described.
    Kokalj Vokac N; Zagorac A; Erjavec Skerget A; Roskar Z; Podgornik H; Cernelc P
    Acta Haematol; 2008; 119(1):54-6. PubMed ID: 18268405
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical usefulness of plasma specimens for detection of nucleophosmin 1 gene mutations in patients with normal karyotype acute myeloid leukemia.
    Park SH; Min SK; Park BG; Jang S; Park CJ; Chi HS
    Leuk Res; 2011 Sep; 35(9):e159-60. PubMed ID: 21600650
    [No Abstract]   [Full Text] [Related]  

  • 34. T-lymphoid/myeloid biphenotypic leukemia morphologically resembling malignant histiocytosis. Immunological, cytogenetic and molecular studies.
    La Starza R; Falini B; Amici A; Falzetti D; Tabilio A; Fagioli M; Martelli MF; Mecucci C
    Haematologica; 1993; 78(3):187-91. PubMed ID: 8375751
    [No Abstract]   [Full Text] [Related]  

  • 35. [Recent advances in the understanding and management of acute myeloid leukemia].
    Lishner M; Buskila D; Ravid M
    Harefuah; 1990 Dec; 119(11):375-8. PubMed ID: 2289717
    [No Abstract]   [Full Text] [Related]  

  • 36. Multiplex reverse transcription polymerase chain reaction screening in acute myeloid leukemia detects cytogenetically unrevealed abnormalities of prognostic significance.
    Hutchings Hoffmann M; Wirenfeldt Klausen T; Hasle H; Schmiegelow K; Brondum-Nielsen K; Johnsen HE
    Haematologica; 2005 Jul; 90(7):984-6. PubMed ID: 15996940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. JAK2-V617F activating mutation in acute myeloid leukemia: prognostic impact and association with other molecular markers.
    Vicente C; Vázquez I; Marcotegui N; Conchillo A; Carranza C; Rivell G; Bandrés E; Cristobal I; Lahortiga I; Calasanz MJ; Odero MD
    Leukemia; 2007 Nov; 21(11):2386-90. PubMed ID: 17581610
    [No Abstract]   [Full Text] [Related]  

  • 38. Proceedings: An appraisal of cytogenetics in leukemia, including a correlation with the evolution and prognosis of acute leukemia.
    Sandberg AA; Sakurai M; Hossfeld DK
    Proc Natl Cancer Conf; 1972; 7():333-43. PubMed ID: 4520051
    [No Abstract]   [Full Text] [Related]  

  • 39. Do chromosome abnormalities determine the type of acute leukemia that develops in CML?
    Bernstein R; Gale RP
    Leukemia; 1990 Jan; 4(1):65-8. PubMed ID: 2296202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined testing for CCAAT/enhancer-binding protein alpha (CEBPA) mutations and promoter methylation in acute myeloid leukemia demonstrates shared phenotypic features.
    Szankasi P; Ho AK; Bahler DW; Efimova O; Kelley TW
    Leuk Res; 2011 Feb; 35(2):200-7. PubMed ID: 20970189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.